Charu Gupta

Charu Gupta

AstraZeneca, Sweden - Södertälje / Sweden
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5681052
-
person_outline Charu Gupta's MOST POPULAR ARTICLES
1-) Long-term safety and efficacy of the Anti-MAdCAM-1 monoclonal antibody ontamalimab [SHP647] for the treatment of ulcerative colitis: the open-label study TURANDOT II Journal of Crohn's and Colitis 15 (6), 938-949, 2021
2-) SO-15 Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma Annals of Oncology 34, S168, 2023
3-) Phase II study of first‐line trebananib plus sorafenib in patients with advanced hepatocellular carcinoma The oncologist 22 (7), 780-e65, 2017
4-) One product, many patents: Imperfect intellectual property rights in the pharmaceutical industry Many Patents: Imperfect Intellectual Property Rights in the Pharmaceutical …, 2023
5-) Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access: Study examines drug repurposing during the COVID-19 Pandemic and offers … Health Affairs 42 (3), 424-432, 2023